Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9089
|
| pubmed:dateCreated |
1997-12-12
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
350
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1476-7; author reply 1477
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9371189-Aspirin,
pubmed-meshheading:9371189-Cerebrovascular Disorders,
pubmed-meshheading:9371189-Humans,
pubmed-meshheading:9371189-Plasminogen Activators,
pubmed-meshheading:9371189-Streptokinase,
pubmed-meshheading:9371189-Thrombolytic Therapy,
pubmed-meshheading:9371189-Tissue Plasminogen Activator
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Thrombolytic therapy for acute ischaemic stroke.
|
| pubmed:publicationType |
Letter,
Comment
|